2013 Press Releases

Keyword Search
 
2017 | 2016 | 2015 | 2014 | 2013
DateTitle 
12/30/13Cipher Announces Change to Board of Directors
Toronto Stock Exchange Symbol: DNDMISSISSAUGA, ON, Dec. 30, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher" or "the Company") today announced that William (Bill) Garriock has resigned from his position of Chair of Cipher, effective December 31, 2013, as he is retiring from active business. Cipher's Board expects to appoint a new Chair in the near future."On behalf of the Board, I would like to thank Bill for his service and contributions and wish him well in retirement," said Larry... 
Printer Friendly Version
10/30/13Cipher reports record financial results for Q3 2013
Revenue increases to $5.6 million and earnings per share rise to $0.14 Toronto Stock Exchange Symbol: DNDMISSISSAUGA,, ON, Oct. 30, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher") today announced its financial and operational results for the three and nine months ended September 30, 2013.Q3 2013 Highlights Net revenue increased to $5.6 million, from $2.1 million in Q3 2012. EBITDA1 of $3.6 million versus $1.0 million in Q3 2012. Net income was $3.4 million, or $0.14 per share, c... 
Printer Friendly Version
10/22/13Notice of Cipher Pharmaceuticals Inc. Q3 2013 Conference Call
Toronto Stock Exchange Symbol: DNDMISSISSAUGA, ON, Oct. 22, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q3 2013 financial results on Wednesday, October 30, 2013.Q3 2013 CONFERENCE CALLWHEN: Wednesday, October 30, 2013 at 8:30AM ETCONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through http://www.cipherpharma.com or http://bit.ly/HfBxkB. An ... 
Printer Friendly Version
09/19/13Cipher's Partner Ranbaxy receives Paragraph IV Certification
Toronto Stock Exchange Symbol: DNDMISSISSAUGA, ON, Sept. 19, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher") today announced that its sales and distribution partner, Ranbaxy Laboratories Inc. ("Ranbaxy") has received a Paragraph IV Certification Notice of filing from Watson Laboratories Inc. of an Abbreviated New Drug Application ("ANDA") to the U.S. Food and Drug Administration ("FDA") for a generic version of Absorica™ (isotretinoin capsules).Ranbaxy and Cipher intend to vigorou... 
Printer Friendly Version
07/31/13Cipher reports record financial results for Q2 2013
Revenue increases to $5.5 million; Company records earnings per share of $0.13Toronto Stock Exchange Symbol: DND MISSISSAUGA, ON, July 31, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher") today announced its financial and operational results for the three and six months ended June 30, 2013.Q2 2013 HighlightsNet revenue increased to $5.5 million, from $1.6 million in Q2 2012.EBITDA of $3.3 million versus $0.4 million in Q2 2012.Net income was $3.1 million, or $0.13 per basic share, ... 
Printer Friendly Version
07/17/13Notice of Cipher Pharmaceuticals Inc. Q2 2013 Conference Call
Toronto Stock Exchange Symbol: DNDMISSISSAUGA, ON, July 17, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND) (OTC: CPHMF), today announced it will host a conference call for its Q2 2013 financial results on Wednesday, July 31, 2013.Q2 2013 CONFERENCE CALLWHEN: Wednesday, July 31, 2013 at 8:30AM ETCONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through http://www.cipherpharma.com or http://bit.ly/15IeDer. An archi... 
Printer Friendly Version
07/02/13Cipher introduces Epuris™ (isotretinoin) capsules in Canadian market
Toronto Stock Exchange Symbol: DNDMISSISSAUGA, ON, July 2, 2013 /CNW/ - At the 88th annual Canadian Dermatology Association Conference held in Quebec City over the July 1st weekend, Cipher Pharmaceuticals Inc. (TSX: DND) ("Cipher") announced the Canadian launch of Epuris™, a novel brand formulation of the acne medication isotretinoin for the treatment of severe acne in patients aged 12 years or older.The Canadian Dermatology Association estimates that acne affects nearly 20%, or 5.6 million, Can... 
Printer Friendly Version
05/03/13Cipher reports record financial results for Q1 2013
- Revenue increases 82%, Company records earnings of $0.06 per share -Toronto Stock Exchange Symbol: DNDMISSISSAUGA, ON, May 3, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND); (OTC: CPHMF) today announced its financial and operational results for the three months ended March 31, 2013.Q1 2013 HighlightsNet revenue increased by 82% over Q1 2012 to $3.3 million.EBITDA of $ 1.7 million versus $0.3 million in Q1 2012.Net income was $1.5 million, or $0.06 per share, compared with net income of $0... 
Printer Friendly Version
04/29/13Cipher Pharmaceuticals completes Latin American distribution and supply agreement for extended-release tramadol
Toronto Stock Exchange Symbol: DNDMISSISSAUGA, ON, April 29, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) today announced it has entered into a definitive distribution and supply agreement with Tecnofarma International Ltd. ("Tecnofarma") under which Cipher has granted Tecnofarma the exclusive right to market, sell and distribute CIP-TRAMADOL ER in Latin America. Tecnofarma, headquartered in Uruguay, operates in 18 Latin American countries and will launch the product in certai... 
Printer Friendly Version
04/15/13Notice of Cipher Pharmaceuticals Inc. Q1 2013 Conference Call and 2012 Annual and Special Meeting of Shareholders
Toronto Stock Exchange Symbol: DNDMISSISSAUGA, ON, April 15, 2013 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: DND; OTC: CPHMF) today announced it will host a conference call for its Q1 2013 financial results and hold its Annual and Special Meeting of Shareholders on Friday, May 3, 2013.Q1 2013 CONFERENCE CALLWHEN: Friday, May 3, 2013 at 8:30AM ETCONFERENCE CALL/WEBCAST: You can join the call by dialing 647-427-7450 or 1-888-231-8191. A live audio webcast will be available through http://www.cipher... 
Printer Friendly Version
<< First | Previous | Next | Last >>